Millrace Asset Group’s Globus Medical GMED Stock Holding History

Millrace Asset Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.66M	Buy	23,151 +977	+4%	+$69K	1.68%	27
2024 Q2	$1.52M	Sell	22,174 -8,411	-28%	-$502K	1.47%	31
2024 Q1	$1.64M	Sell	30,585 -8,872	-22%	-$477K	1.65%	25
2023 Q4	$2.1M	Buy	+39,457	New	+$1.92M	2.08%	10
2019 Q1	–	Sell	-32,000	Closed	-$1.39M	–	65
2018 Q4	$1.39M	Buy	+32,000	New	+$1.6M	1.27%	45
2018 Q3	–	Sell	-16,857	Closed	-$851K	–	70
2018 Q2	$851K	Buy	16,857 +2,357	+16%	+$123K	0.65%	61
2018 Q1	$723K	Sell	14,500 -29,000	-67%	-$1.36M	0.7%	56
2017 Q4	$1.79M	Sell	43,500 -18,000	-29%	-$630K	1.72%	31
2017 Q3	$1.83M	Buy	+61,500	New	+$1.88M	1.72%	23
2015 Q3	–	Sell	-48,844	Closed	-$1.25M	–	55
2015 Q2	$1.25M	Buy	+48,844	New	+$1.24M	1.31%	40

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Millrace Asset Group's GMED Position: Q3 2024 in Review

Millrace Asset Group increased its Globus Medical (GMED) stake by 4.4% in Q3 2024, buying an estimated $69K and bringing the position to 23,151 shares worth $1.66M. The position accounts for 1.68% of the portfolio, ranked #27.

Millrace Asset Group first reported a position in GMED in Q2 2015 and has held it in 10 quarters since. The position peaked at $2.1M in Q4 2023. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

Millrace Asset Group held 23,151 shares of Globus Medical worth $1.66M as of Q3 2024.
Millrace Asset Group bought 977 Globus Medical shares in Q3 2024, an estimated $69K.
Globus Medical made up 1.68% of Millrace Asset Group's portfolio in Q3 2024, its #27 holding.
Millrace Asset Group first reported a position in Globus Medical in Q2 2015 and has held it in 10 quarters since.
Millrace Asset Group's Globus Medical position peaked at $2.1M in Q4 2023.
449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.